Publications by authors named "Thorsten Raff"

Claim this Profile
A
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
Vincent H J van der Velden, Isabel Dombrink, Julia Alten, Giovanni Cazzaniga, Emmanuelle Clappier, Thorsten Raff

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERRATUM.
Eugenia Tsakou, Andreas Agathagelidis, Myriam Boudjoghra, Thorsten Raff, Antonis Dagklis

Mol Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Anna Czajczynska, Andreas Günther, Roland Repp, Andreas Humpe, Natalie Schub, Thorsten Raff

Biol Blood Marrow Transplant· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.
Martin Neumann, Sandra Heesch, Cornelia Schlee, Stefan Schwartz, Nicola Gökbuget, Thorsten Raff

Blood· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.
Max S Topp, Nicola Gökbuget, Gerhard Zugmaier, Evelyn Degenhard, Marie-Elisabeth Goebeler, Thorsten Raff

Blood· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has MRD monitoring superseded other prognostic factors in adult ALL?
Monika Brüggemann, Thorsten Raff, Michael Kneba

Blood· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.
Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, Claus-Rainer Bartram

Blood· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.
Eugenia Tsakou, Andreas Agathangelidis, Andreas Agathagelidis, Myriam Boudjoghra, Thorsten Raff

Mol Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.
Max S Topp, Peter Kufer, Nicola Gökbuget, Mariele Goebeler, Matthias Klinger, Thorsten Raff

J Clin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug resistance-associated protein 4 (MRP4) gene polymorphisms and treatment response in adult acute lymphoblastic leukemia.
Monika Brüggemann, Heiko Trautmann, Dieter Hoelzer, Michael Kneba, Nicola Gökbuget, Thorsten Raff

Blood· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.
Thomas Burmeister, Claus Meyer, Stefan Schwartz, Julia Hofmann, Mara Molkentin, Thorsten Raff

Blood· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials.
Thorsten Raff, Nicola Gökbuget, Silke Lüschen, Regina Reutzel, Matthias Ritgen

Blood· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma.
Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff

Blood· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.
Monika Brüggemann, Thorsten Raff, Thomas Flohr, Nicola Gökbuget, Makoto Nakao

Blood· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphism.
Sebastian Böttcher, Matthias Ritgen, Monika Brüggemann, Thorsten Raff, Silke Lüschen

J Immunol Methods· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Christiane Pott, Carsten Schrader, Monika Brüggemann, Matthias Ritgen, Lana Harder, Thorsten Raff

Eur J Haematol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
Matthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, Andreas Humpe, Monika Brüggemann, Thorsten Raff

Blood· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benign gynecological tumors: estimated incidence. Results of the German Cohort Study on Women's Health.
Klaas Heinemann, Christine Thiel, Sabine Möhner, Michael A Lewis, Thorsten Raff

Eur J Obstet Gynecol Reprod Biol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted treatment according to minimal residual disease in adult ALL.
Nicola Gökbuget, Michael Kneba, Thorsten Raff, Monika Bruggemann, Urban Scheuring

Best Pract Res Clin Haematol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis